Look Who’s On the Move!

      ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs

      MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs. In this newly created role, Ms. Jefferson will be responsible for the strategic leadership, development, and management of ReCode’s external and employee communications initiatives, including media, investor, an

      GoodRx Appoints Dorothy Gemmell as Chief Commercial Officer

      SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the appointment of Dorothy Gemmell as Chief Commercial Officer, effective July 3, 2023. Gemmell will work closely with Aaron Crittenden, newly appointed Chief Revenue Officer, and together they will lead the company’s Pharma Manufacturer Solutions business, which provides solutions for pharmaceutical and medical device companies. Gemmell brings with her a stro

      FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors

      TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, today announces appointment of Zeeshan Saeed as Chief Executive Officer (“CEO”) of the Company. Mr. Saeed, a Co-Founder of FSD Pharma who has held the position of President since 2019, was e

      Apogee Therapeutics Strengthens Team with Appointments of Industry Leaders to Board of Directors and Management

      SAN FRANCISCO & WALTHAM, Mass.--(BUSINESS WIRE)--Apogee Therapeutics, a biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and related inflammatory and immunology indications, today announced the appointments of Jennifer Fox and William “BJ” Jones, seasoned executives in the biotechnology industry, to its board of directors. Ms. Fox will also serve as chair of the company’s audit committee. Additionally, Apogee

      IPS Strengthens Asia and Pacific Presence with New Managing Director, Matthew Shippey

      BLUE BELL, Pa.--(BUSINESS WIRE)--IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services, announces the appointment of an industry-leading professional, Matthew Shippey, to support the company’s continued growth in the Asia Pacific (APAC) Region. With over 35 years of strategic leadership experience across multiple industries, Matthew’s arrival marks a significant milestone in the company’s growth and momentum in the APAC market. Matth

      Graphite Bio Announces Departure of Chief Financial Officer

      SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $GRPH #GraphiteBio--Graphite Bio, Inc. (Nasdaq: GRPH) today announced that Alethia Young, the Company’s Chief Financial Officer, will step down from her position to pursue other opportunities. Ms. Young will remain with the Company through June 30, 2023 to oversee her current responsibilities and ensure an orderly transition. “On behalf of the Board and the team at Graphite Bio, I would like to thank Alethia for her dedication and support. She has been an integral part

      Recent Articles